Current approaches to novel therapeutics in pancreatic cancer.

摘要: Pancreatic cancer is one of the most refractory neoplasms to medical treatment. Until now there has been only modest improvement in treatment this disease. Standards care for combined-modality resectable as well locally advanced, unresectable disease have not uniformly accepted date because an equivocal or conflicting data. The inception gemcitabine introduced new era management metastatic pancreatic cancer, however, therapeutic approaches still need be defined. article discusses current knowledge biology lethal disease, its impact on options, and explores novel modalities that are likely improve outcomes survival patients future.